查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1224649

北美体外诊断市场规模、份额和趋势分析报告：按产品（设备、试剂、服务）、技术、应用、最终用途、测试地点、地区、细分市场预测，2023-2030 年

North America In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents, Services), By Technology, By Application, By End-use, By Test Location, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 280 Pages | 商品交期: 2-10个工作天内

价格

北美体外诊断市场的增长和趋势

根据 Grand View Research, Inc. 的最新报告，北美体外诊断市场规模预计到 2030 年将达到 396.7 亿美元，2023 年至 2030 年的复合年增长率为 2.89%。我来了。 同时，市场也有望在关键领域迎来各种增长机会。 例如，为医院和实验室开发自动化体外诊断解决方案以提供准确、高效和无差错的诊断，预计将在未来几年推动市场增长。 此外，开发 POC 解决方案的努力不断增加，以及在传染病、妊娠和癌症等各种医学诊断应用中采用 POC 测试的激增正在推动市场的增长。

主要进入者加大力度开发快速准确的产品，以实现易于使用、先进和灵活的检测选项，预计这将推动市场增长。 例如，2022 年 8 月，DxGen Corp. 和 Precision Diabetes, Inc. 宣布达成协议，将在美国市场开发和推出用于糖尿病检测的全自动 POC 分析仪。 该分析仪可以在 POC 设施进行 CRP、尿液分析、A1C 值和其他糖尿病确认测试。

此外，2021 年 11 月，领先的 POC 诊断公司 Lumos Diagnostics 宣布 Lumos CoviDx SARS-CoV-2 快速抗原检测获得加拿大卫生部的中单授权。 该测试在无症状患者的连续测试中仅需 15-20 分钟即可提供易于解释的结果。 家庭保健、社区药房、零售诊所、急救医疗中心、重症监护病房和手术室中即时检测的便捷可用性正在推动 POC IVD 产品在该地区的广泛采用。

随着诊断实验室频繁采用全自动工具，北美体外诊断行业的发展势头越来越好。 此外，自动化设备具有高度可扩展性，满足高性能期望，消除批量测试，并为医疗保健专业人员提供快速结果。 由于这些优势，领先的参与者不断致力于构建自动化设备。 例如，2022年5月，BD在美国市场推出了全新的全自动高通量传染病分子诊断平台。

此外，该地区目标疾病发病率的增加、有利的政府举措以及蓬勃发展的医疗保健行业预计将提供有利可图的增长机会。

例如，2022 年 11 月，Hologic 从 BARDA 获得了一份价值 1900 万美元的合同，以支持其研发活动。 同样在 2022 年 1 月，Aline, Inc. 和 Nectar Product Development 宣布建立战略合作伙伴关係，以改进 POC 体外诊断。

北美体外诊断市场报告要点

试剂行业在 2022 年占据了最大的市场份额，这是由于主要市场参与者为开发新型检测试剂盒采取了广泛的研发举措

由于技术的快速发展、疾病负担的增加以及主要进入者产品发布的激增，分子诊断领域在 2022 年占据了最大的市场份额

按应用划分，传染病领域将在 2022 年的收入份额方面占据市场主导地位。 另一方面，肿瘤部分预计在预测期内增长最快

由于对负担得起的服务的需求不断增加、个性化护理趋势激增、优惠报销政策的存在等，到 2022 年，医院部门将成为最大的最终用户。

由于老年人口不断增加，患者人数众多，慢性病患病率高，预计加拿大在预测期内将出现最快的增长

Contents

第一章调查方法及范围

  • 市场细分和范围
  • 调查方法
  • 信息采购
    • 购买的数据库：
    • GVR 内部数据库
    • 次要信息
    • 初步调查
  • 信息或数据分析
    • 数据分析模型
  • 市场製定和验证
  • 模型详细信息
    • 商品流分析（模型 1）
      • 方法 1：商品流方法
  • 调查假设
  • 次要信息列表
  • 缩写列表
  • 目的

第 2 章执行摘要

  • 市场概况
  • 片段快照
  • 竞争格局快照

第 3 章北美体外诊断市场变量、趋势和范围

  • 体外诊断市场体系展望
    • 母公司市场展望
  • 描绘渗透率和增长前景
  • 市场驱动因素分析
    • 不断增长的老年人口
    • 技术进步
    • 对 POC 设施的需求增加
    • 目标疾病的患病率，例如遗传病、心血管疾病、神经系统疾病和院内感染
    • COVID-19 爆发
  • 市场製约因素分析
    • 设备成本高
    • 严格的监管政策
  • SWOT 分析，按因素（政治和法律、经济、技术）
  • 波特的五力分析
  • 管道阶段分析
  • 监管和报销方案
  • 价格分析

第 4 章北美体外诊断市场细分分析，副产品，2018-2030（数量、测试和仪器数量、收入，百万美元，2018-2030）

  • 北美体外诊断市场：产品差异分析
  • 设备
    • 医院
    • 实验室
    • 家庭护理
    • 诊所
      • 医务室
      • 药房和零售诊所
      • 非临床
      • 紧急治疗门诊
      • 其他
  • 试剂
    • 医院
    • 实验室
    • 家庭护理
    • 诊所
      • 医务室
      • 药房和零售诊所
      • 非临床
      • 紧急治疗门诊
      • 其他
  • 服务
    • 医院
    • 实验室
    • 家庭护理
    • 诊所
      • 医务室
      • 药房和零售诊所
      • 非临床
      • 紧急治疗门诊
      • 其他

第 5 章北美体外诊断市场细分分析，按技术分类，2018-2030 年（收入，百万美元）（数量、测试数量和设备）

  • 北美体外诊断市场：技术波动分析
  • 免疫测定
    • 产品
      • 设备
      • 试剂
      • 服务
    • 最终用途
      • 医院
      • 实验室
      • 家庭护理
      • 诊所
      • 医务室
      • 药房和零售诊所
      • 非临床
      • 紧急治疗门诊
      • 其他
  • 血液学
    • 产品
      • 设备
      • 试剂
      • 服务
    • 最终用途
      • 医院
      • 实验室
      • 家庭护理
      • 诊所
      • 医务室
      • 药房和零售诊所
      • 非临床
      • 紧急治疗门诊
      • 其他
  • 临床化学
    • 产品
      • 设备
      • 试剂
      • 服务
    • 最终用途
      • 医院
      • 实验室
      • 家庭护理
      • 诊所
      • 医务室
      • 药房和零售诊所
      • 非临床
      • 紧急治疗门诊
      • 其他
  • 分子诊断
    • 产品
      • 设备
      • 试剂
      • 服务
    • 最终用途
      • 医院
      • 实验室
      • 家庭护理
      • 诊所
      • 医务室
      • 药房和零售诊所
      • 非临床
      • 紧急治疗门诊
      • 其他
  • 凝血
    • 产品
      • 设备
      • 试剂
      • 服务
    • 最终用途
      • 医院
      • 实验室
      • 家庭护理
      • 诊所
      • 医务室
      • 药房和零售诊所
      • 非临床
      • 紧急治疗门诊
      • 其他
  • 微生物学
    • 产品
      • 设备
      • 试剂
      • 服务
    • 最终用途
      • 医院
      • 实验室
      • 家庭护理
      • 诊所
      • 医务室
      • 药房和零售诊所
      • 非临床
      • 紧急治疗门诊
      • 其他
  • 其他
    • 设备
    • 试剂
    • 服务

第 6 章北美体外诊断市场：细分分析，按应用，2018-2030（百万美元）

  • 北美体外诊断市场：应用差异分析
  • 感染
    • 疾病
      • 耐甲氧西林金黄色葡萄球菌 (Mrsa)
      • 艰难梭菌
      • 耐万古霉素肠球菌 (Vre)
      • 耐碳青霉烯类细菌
Product Code: GVR-4-68040-028-3

North America In Vitro Diagnostics Market Growth & Trends:

The North America in vitro diagnostics market size is expected to reach USD 39.67 billion by 2030 and is expected to decline at 2.89% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. On the other hand, the market is also expected to cater to various growth opportunities in key segments. For example, the development of automated in vitro diagnostic solutions for hospitals and laboratories to provide accurate, efficient, and error-free diagnosis is anticipated to drive market growth in the coming years. In addition, rising efforts to develop POC solutions and the surge in adoption of POC tests across different medical diagnostic applications, including infectious diseases, pregnancy, cancer, and others, are fueling the market growth.

The market growth is likely to be fueled by rising efforts from leading participants to develop fast and accurate products that allow easy-to-use, advanced, and flexible testing options. For instance, in August 2022, DxGen Corp. and Precision Diabetes, Inc. announced an agreement to develop and launch a fully automatic POC analyzer in the U.S. market to measure a complete profile of diabetes tests. The analyzer is capable to test C-reactive protein, urine analysis, A1C levels, and other diabetes confirmatory tests at POC facilities.

Furthermore, in November 2021, Lumos Diagnostics, a key player in POC diagnostics, announced that its Lumos CoviDx SARS-CoV-2 Rapid Antigen Test received an interim order authorization from Health Canada. This test offers easy-to-interpret outcomes in just 15-20 minutes in serial testing of asymptomatic patients. The easy availability of point-of-care tests in home care settings, community pharmacies, retail health clinics, urgent care centers, intensive care units, and operating rooms is fueling the adoption of POC IVD products across the region.

The North America in vitro diagnostics industry is gaining traction as diagnostic laboratories frequently employ fully automated tools. Moreover, automated devices are highly scalable, meet a high level of performance expectations, eliminate batch testing, and provide quick results to medical professionals. Leading participants are continuously working on building automated devices because of these benefits. For instance, in May 2022, BD launched a new, fully automated high-throughput infectious disease molecular diagnostics platform in the U.S. market.

Furthermore, the increasing incidence of target diseases, favorable government initiatives, and the flourishing healthcare sector in the region are anticipated to offer lucrative growth opportunities.

For instance, in November 2022, Hologic, Inc. was awarded a USD 19 million contract from BARDA to support its research and development activities. In addition, in January 2022, Aline, Inc. & Nectar Product Development announced a strategic partnership to improve POC in vitro diagnostic products.

North America In Vitro Diagnostics Market Report Highlights:

  • The reagents segment held the largest market share in 2022 owing to extensive R&D initiatives being undertaken by major market players for the development of novel test kits
  • The molecular diagnostics segment accounted for the largest market share in 2022, thanks to rapid evolution in technology, increasing burden of target diseases, and surge in product launches by leading participants
  • Based on application, the infectious disease segment dominated the market in terms of revenue share in 2022. On the other hand, the oncology segment is expected to be the fastest-growing segment over the forecast period
  • The hospitals segment was the largest end-user in 2022, owing to the rising demand for affordable services, the surging trend for personalized treatments, and the presence of favorable reimbursement policies
  • Canada is expected to exhibit the fastest growth over the forecast period in the region due to the increasing geriatric population, and large patient pool with a high prevalence of chronic diseases

Table of Contents

Chapter 1 Methodology And Scope

  • 1.1 Market Segmentation And Scope
    • 1.1.1 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database:
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis (Model 1)
      • 1.6.1.1 Approach 1: Commodity Flow Approach
  • 1.7 Research Assumptions
  • 1.8 List Of Secondary Sources
  • 1.9 List Of Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective 1
    • 1.10.2 Objective 2
    • 1.10.3 Objective 3
    • 1.10.4 Objective 4

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Segment Snapshot
  • 2.3 Competitive Landscape Snapshot

Chapter 3 North America Ivd Market Variables, Trends, & Scope

  • 3.1 Ivd Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
  • 3.2 Penetration And Growth Prospect Mapping
  • 3.3 Market Driver Analysis
    • 3.3.1 Growing Geriatric Population
    • 3.3.2 Technological Advancements
    • 3.3.3 Increasing Demand For Poc Facilities
    • 3.3.4 Growing Prevalence Of Target Diseases Such As Genetic, Cardiovascular, & Neurological Diseases And Hospital-Acquired Infections
    • 3.3.5 Outbreak Of Covid-19
  • 3.4 Market Restraint Analysis
    • 3.4.1 High Cost Of Devices
    • 3.4.2 Stringent Regulatory Policies
  • 3.5 Swot Analysis, By Factor (Political & Legal, Economic, And Technological)
  • 3.6 Porter's Five Forces Analysis
  • 3.7 Pipeline Analysis, By Phase
  • 3.8 Regulatory & Reimbursement Scenario
  • 3.9 Pricing Analysis

Chapter 4 North America Ivd Market-Segment Analysis, By Product, 2018 - 2030 (Volume, Number Of Tests And Instruments; Revenue, USD Million, 2018 - 2030)

  • 4.1 North America In Vitro Diagnostic Market: Products Movement Analysis
  • 4.2 Instruments
    • 4.2.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.2.2 Hospitals
      • 4.2.2.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.2.3 Laboratories
      • 4.2.3.1 Laboratories Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.2.4 Home Care
      • 4.2.4.1 Home Care Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.2.5 Clinic
      • 4.2.5.1 Clinic Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.2.5.2 Physician Office
      • 4.2.5.2.1 Physician Office Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.2.5.3 Pharmacy & Retail Clinics
      • 4.2.5.3.1 Pharmacy & Retail Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.2.5.4 Non-Practice Clinics
      • 4.2.5.4.1 Non-Practice Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.2.5.5 Urgent Care Clinics
      • 4.2.5.5.1 Urgent Care Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.2.5.6 Others
      • 4.2.5.6.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.3 Reagents
    • 4.3.1 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.3.2 Hospitals
      • 4.3.2.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.3.3 Laboratories
      • 4.3.3.1 Laboratories Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.3.4 Home Care
      • 4.3.4.1 Home Care Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.3.5 Clinic
      • 4.3.5.1 Clinic Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.3.5.2 Physician Office
      • 4.3.5.2.1 Physician Office Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.3.5.3 Pharmacy & Retail Clinics
      • 4.3.5.3.1 Pharmacy & Retail Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.3.5.4 Non-Practice Clinics
      • 4.3.5.4.1 Non-Practice Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.3.5.5 Urgent Care Clinics
      • 4.3.5.5.1 Urgent Care Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.3.5.6 Others
      • 4.3.5.6.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.4 Services
    • 4.4.1 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.4.2 Hospitals
      • 4.4.2.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.4.3 Laboratories
      • 4.4.3.1 Laboratories Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.4.4 Home Care
      • 4.4.4.1 Home Care Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.4.5 Clinic
      • 4.4.5.1 Clinic Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.4.5.2 Physician Office
      • 4.4.5.2.1 Physician Office Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.4.5.3 Pharmacy & Retail Clinics
      • 4.4.5.3.1 Pharmacy & Retail Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.4.5.4 Non-Practice Clinics
      • 4.4.5.4.1 Non-Practice Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.4.5.5 Urgent Care Clinics
      • 4.4.5.5.1 Urgent Care Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.4.5.6 Others
      • 4.4.5.6.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 5 North America Ivd Market-Segment Analysis, By Technology, 2018 - 2030 (Revenue, USD Million) (Volume, Number Of Test And Instruments)

  • 5.1 North America In Vitro Diagnostics Market: Technology Movement Analysis
  • 5.2 Immunoassay
    • 5.2.1 Immunoassay Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.2.2 Products
      • 5.2.2.1 Instruments
      • 5.2.2.1.1 Instruments Market For Immunoassay Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.2.2 Reagents
      • 5.2.2.2.1 Reagents Market For Immunoassay Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.2.3 Services
      • 5.2.2.3.1 Services Market For Immunoassay Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.2.3 End-Use
      • 5.2.3.1 Hospitals
      • 5.2.3.1.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.3.2 Laboratories
      • 5.2.3.2.1 Laboratories Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.3.3 Home Care
      • 5.2.3.3.1 Home Care Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.3.4 Clinic
      • 5.2.3.4.1 Clinic Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.3.4.2 Physician Office
      • 5.2.3.4.2.1 Physician Office Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.3.4.3 Pharmacy & Retail Clinics
      • 5.2.3.4.3.1 Pharmacy & Retail Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.3.4.4 Non-Practice Clinics
      • 5.2.3.4.4.1 Non-Practice Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.3.4.5 Urgent Care Clinics
      • 5.2.3.4.5.1 Urgent Care Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.3.4.6 Others
      • 5.2.3.4.6.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.3 Hematology
    • 5.3.1 Hematology Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.3.2 Products
      • 5.3.2.1 Instruments
      • 5.3.2.1.1 Instruments Market For Hematology Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.3.2.2 Reagents
      • 5.3.2.2.1 Reagents Market For Hematology Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.3.2.3 Services
      • 5.3.2.3.1 Services Market For Hematology Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.3.3 End-Use
      • 5.3.3.1 Hospitals
      • 5.3.3.1.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.3.3.2 Laboratories
      • 5.3.3.2.1 Laboratories Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.3.3.3 Home Care
      • 5.3.3.3.1 Home Care Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.3.3.4 Clinic
      • 5.3.3.4.1 Clinic Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.3.3.4.2 Physician Office
      • 5.3.3.4.2.1 Physician Office Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.3.3.4.3 Pharmacy & Retail Clinics
      • 5.3.3.4.3.1 Pharmacy & Retail Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.3.3.4.4 Non-Practice Clinics
      • 5.3.3.4.4.1 Non-Practice Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.3.3.4.5 Urgent Care Clinics
      • 5.3.3.4.5.1 Urgent Care Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.3.3.4.6 Others
      • 5.3.3.4.6.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.4 Clinical Chemistry
    • 5.4.1 Clinical Chemistry Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.4.2 Products
      • 5.4.2.1 Instruments
      • 5.4.2.1.1 Instruments Market For Clinical Chemistry Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.4.2.2 Reagents
      • 5.4.2.2.1 Reagents Market For Clinical Chemistry Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.4.2.3 Services
      • 5.4.2.3.1 Services Market For Clinical Chemistry Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.4.3 End-Use
      • 5.4.3.1 Hospitals
      • 5.4.3.1.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.4.3.2 Laboratories
      • 5.4.3.2.1 Laboratories Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.4.3.3 Home Care
      • 5.4.3.3.1 Home Care Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.4.3.4 Clinic
      • 5.4.3.4.1 Clinic Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.4.3.4.2 Physician Office
      • 5.4.3.4.2.1 Physician Office Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.4.3.4.3 Pharmacy & Retail Clinics
      • 5.4.3.4.3.1 Pharmacy & Retail Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.4.3.4.4 Non-Practice Clinics
      • 5.4.3.4.4.1 Non-Practice Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.4.3.4.5 Urgent Care Clinics
      • 5.4.3.4.5.1 Urgent Care Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.4.3.4.6 Others
      • 5.4.3.4.6.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.5 Molecular Diagnostics
    • 5.5.1 Molecular Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.5.2 Products
      • 5.5.2.1 Instruments
      • 5.5.2.1.1 Instruments Market For Molecular Diagnostics Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.5.2.2 Reagents
      • 5.5.2.2.1 Reagents Market For Molecular Diagnostics Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.5.2.3 Services
      • 5.5.2.3.1 Services Market For Molecular Diagnostics Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.5.3 End-Use
      • 5.5.3.1 Hospitals
      • 5.5.3.1.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.5.3.2 Laboratories
      • 5.5.3.2.1 Laboratories Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.5.3.3 Home Care
      • 5.5.3.3.1 Home Care Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.5.3.4 Clinic
      • 5.5.3.4.1 Clinic Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.5.3.4.2 Physician Office
      • 5.5.3.4.2.1 Physician Office Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.5.3.4.3 Pharmacy & Retail Clinics
      • 5.5.3.4.3.1 Pharmacy & Retail Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.5.3.4.4 Non-Practice Clinics
      • 5.5.3.4.4.1 Non-Practice Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.5.3.4.5 Urgent Care Clinics
      • 5.5.3.4.5.1 Urgent Care Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.5.3.4.6 Others
      • 5.5.3.4.6.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.6 Coagulation
    • 5.6.1 Coagulation Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.6.2 Products
      • 5.6.2.1 Instruments
      • 5.6.2.1.1 Instruments Market For Coagulation Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.6.2.2 Reagents
      • 5.6.2.2.1 Reagents Market For Coagulation Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.6.2.3 Services
      • 5.6.2.3.1 Services Market For Coagulation Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.6.3 End-Use
      • 5.6.3.1 Hospitals
      • 5.6.3.1.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.6.3.2 Laboratories
      • 5.6.3.2.1 Laboratories Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.6.3.3 Home Care
      • 5.6.3.3.1 Home Care Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.6.3.4 Clinic
      • 5.6.3.4.1 Clinic Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.6.3.4.2 Physician Office
      • 5.6.3.4.2.1 Physician Office Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.6.3.4.3 Pharmacy & Retail Clinics
      • 5.6.3.4.3.1 Pharmacy & Retail Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.6.3.4.4 Non-Practice Clinics
      • 5.6.3.4.4.1 Non-Practice Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.6.3.4.5 Urgent Care Clinics
      • 5.6.3.4.5.1 Urgent Care Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.6.3.4.6 Others
      • 5.6.3.4.6.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.7 Microbiology
    • 5.7.1 Microbiology Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.7.2 Products
      • 5.7.2.1 Instruments
      • 5.7.2.1.1 Instruments Market For Microbiology Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.7.2.2 Reagents
      • 5.7.2.2.1 Reagents Market For Microbiology Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.7.2.3 Services
      • 5.7.2.3.1 Services Market For Microbiology Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.7.3 End-Use
      • 5.7.3.1 Hospitals
      • 5.7.3.1.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.7.3.2 Laboratories
      • 5.7.3.2.1 Laboratories Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.7.3.3 Home Care
      • 5.7.3.3.1 Home Care Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.7.3.4 Clinic
      • 5.7.3.4.1 Clinic Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.7.3.4.2 Physician Office
      • 5.7.3.4.2.1 Physician Office Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.7.3.4.3 Pharmacy & Retail Clinics
      • 5.7.3.4.3.1 Pharmacy & Retail Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.7.3.4.4 Non-Practice Clinics
      • 5.7.3.4.4.1 Non-Practice Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.7.3.4.5 Urgent Care Clinics
      • 5.7.3.4.5.1 Urgent Care Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.7.3.4.6 Others
      • 5.7.3.4.6.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.8 Others
    • 5.8.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.8.2 Instruments
      • 5.8.2.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.8.3 Reagents
      • 5.8.3.1 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.8.4 Services
      • 5.8.4.1 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 6 North America Ivd Market: Segment Analysis, By Application, 2018 - 2030 (USD Million)

  • 6.1 North America In Vitro Diagnostics Market: Application Movement Analysis
  • 6.2 Infectious Diseases
    • 6.2.1 Infectious Diseases Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.2 Disease
      • 6.2.2.1. Methicillin-Resistant Staphylococcus Aureus (Mrsa)
      • 6.2.2.1.1 Methicillin-Resistant Staphylococcus Aureus (Mrsa) Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.1.2 Clostridium Difficile
      • 6.2.2.1.2.1 Clostridium Difficile Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.1.3 Vancomycin-Resistant Enterococci (Vre)
      • 6.2.2.1.3.1 Vancomycin-Resistant Enterococci (Vre) Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.1.4 Carbapenem-Resistant Bacteria
      • 6.2.2.1.4.1 Carbapenem-Resistant Bacteria Market Estimates And Forecast, 2018 - 2030 (USD Million)

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Leading Market Players Anticipated to Witness Highest Growth
  • Table 4 North America In Vitro Diagnostics Market, By Country, 2018 - 2030 (USD Million)
  • Table 5 North America In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of Tests & Instruments)
  • Table 6 North America In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of Tests & Instruments)
  • Table 7 North America In Vitro Diagnostics Market, By Route of Application, 2018 - 2030 (USD Million)
  • Table 8 North America In Vitro Diagnostics Market, By End-Use, 2018 - 2030 (USD Million) (Number of Tests & Instruments)
  • Table 9 North America In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million)
  • Table 10 U.S. In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of Tests & Instruments)
  • Table 11 U.S. In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of Tests & Instruments)
  • Table 12 U.S. In Vitro Diagnostics Market, By Route of Application, 2018 - 2030 (USD Million)
  • Table 13 U.S. In Vitro Diagnostics Market, By End-Use, 2018 - 2030 (USD Million) (Number of Tests & Instruments)
  • Table 14 U.S. In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million)
  • Table 15 Canada In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million) (Number of Tests & Instruments)
  • Table 16 Canada In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million) (Number of Tests & Instruments)
  • Table 17 Canada In Vitro Diagnostics Market, By Route of Application, 2018 - 2030 (USD Million)
  • Table 18 Canada In Vitro Diagnostics Market, By End-Use, 2018 - 2030 (USD Million) (Number of
  • Table 19 Canada In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 North America in vitro diagnostics market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market snapshot
  • Fig. 10 Segment snapshot
  • Fig. 11 Segment snapshot
  • Fig. 12 Segment snapshot
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Penetration and growth prospect mapping
  • Fig. 15 North America in vitro diagnostic market driver impact
  • Fig. 16 Geriatric population in the U.S.
  • Fig. 17 Comparison of geriatric population in the U.S.
  • Fig. 18 Proportion of Canadian population in 2022
  • Fig. 19 Number of deaths for leading causes of death
  • Fig. 20 North America in vitro diagnostics market restraint impact
  • Fig. 21 SWOT analysis, by factor (political & legal, economic, and technological)
  • Fig. 22 Porter's five forces analysis
  • Fig. 23 Taking control of the changing regulatory landscape
  • Fig. 24 North America IVD market: Product outlook and key takeaways
  • Fig. 25 North America. IVD market: Products movement analysis
  • Fig. 26 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Laboratories market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Home care market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Clinic market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Physician office market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Pharmacy & retail clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Non-practice clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Urgent care clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Laboratories market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Home care market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Clinic market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Physician office market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Pharmacy & retail clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Non-practice clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Urgent care clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Laboratories market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Home care market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Clinic market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Physician office market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Pharmacy & retail clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Non-practice clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Urgent care clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 North America IVD market: Technology outlook and key takeaways
  • Fig. 57 North America IVD market: Technology movement analysis
  • Fig. 58 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Instruments market for immunoassay estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Reagents market for immunoassay estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Services market for immunoassay estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Laboratories market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Instruments market for clinical chemistry estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Pharmacy & retail clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Services market for other technology estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 North America IVD market: Application outlook and key takeaways
  • Fig. 68 North America IVD market: Application movement analysis
  • Fig. 69 Meningitis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 Percentage of osteoporosis affecting men and women
  • Fig. 71 North America IVD market: End-use outlook and key takeaways
  • Fig. 72 Home care market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 73 Key stats related to retail clinics in the U.S.
  • Fig. 74 Regional marketplace: Key takeaways
  • Fig. 75 North America: SWOT analysis
  • Fig. 76 North America IVD market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 Risk factors and major chronic diseases in the U.S.
  • Fig. 79 U.S. healthcare reimbursement and financing structure
  • Fig. 80 U.S. IVD market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Target disease prevalence in Canada
  • Fig. 83 Canada IVD market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Market participant categorization
  • Fig. 85 North America IVD market share analysis, 2022
  • Fig. 86 Strategic framework
  • Fig. 87 Competition categorization
  • Fig. 88 Company market position analysis
  • Fig. 89 Company market position analysis
  • Fig. 90 Company market position analysis
  • Fig. 91 Regional network map